Increased variability [GxP / QC / QA]

posted by ElMaestro  – Denmark, 2021-09-17 20:51 (1343 d 23:59 ago) – Posting: # 22586
Views: 11,297

Hi all,

❝ ❝ The CVs calculated from the confidence intervals in both ‘parts’ are much lower than the ones in the ‘full’ study. Or the other way ’round: If we pool the CVs of the ‘parts’ we could expect values which are lower than the ‘observed’ (tee-hee!) ones.


Correctly observed. And for exactly those reasons it makes very good sense to plot for example the RMSE, CV, SE of diff., or even the width of the CI as function of (cumulated) number of subjects.

It is not so difficult. :-)
—
Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
65 visitors (0 registered, 65 guests [including 40 identified bots]).
Forum time: 20:50 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5